Viveon Health Acquisition (VHAQ) Stock Chart & Stock Price History → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free VHAQ Stock Alerts $10.00 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial Media Viveon Health Acquisition Stock Price Performance5 Day Performance+11.11%1 Month PerformanceN/A3 Month Performance-11.43%6 Month Performance-12.28%Year-To-Date Performance-11.35%1 Year Performance-9.09% Receive VHAQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Viveon Health Acquisition and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him VHAQ Stock Chart for Thursday, April, 25, 2024 VHAQ Chart by TradingView Viveon Health Acquisition Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/22/2024$10.00$10.00$10.00$10.00400 shs$66.50 million04/19/2024$9.00$9.00$9.00$9.008 shs$59.85 million04/18/2024$9.00$9.00$9.00$9.008 shs$59.84 million04/17/2024$9.00$9.00$9.00$9.004 shs$59.85 million04/08/2024$9.00$9.00$9.00$9.00100 shs$59.85 million04/05/2024$9.00$9.00$9.00$9.003 shs$59.85 million Get the Latest News and Ratings for VHAQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viveon Health Acquisition and its competitors with MarketBeat's FREE daily newsletter. 04/04/2024$9.00$9.00$9.00$9.003 shs$59.84 million03/26/2024$9.00$9.00$9.00$9.009 shs$59.85 million03/25/2024$9.00$9.00$9.00$9.00100 shs$59.85 million03/20/2024$0.00$0.00$0.00$0.00104 shs$12,000.0003/19/2024$0.00$0.00$0.00$0.00104 shs$12,000.0003/18/2024$0.00$0.00$0.00$0.00604 shs$12,000.0003/14/2024$0.00$0.00$0.00$0.00104 shs$12,000.0003/13/2024$0.00$0.00$0.00$0.00104 shs$12,000.0003/12/2024$10.81$0.00-99.98%$0.00$0.00550 shs$12,000.0003/11/2024$10.81$10.81$11.25$10.81550 shs$71.89 million02/26/2024$10.81$10.81$11.25$10.813,600 shs$71.89 million02/22/2024$10.81$10.81$11.25$10.813,627 shs$71.89 million02/21/2024$11.15$10.81-3.05%$11.25$10.813,627 shs$71.89 million02/20/2024$11.50$11.15-3.04%$11.68$11.1510,009 shs$74.15 million02/19/2024$11.50$11.50$11.90$11.3012,300 shs$76.48 million02/16/2024$11.48$11.50+0.17%$11.90$11.3012,334 shs$76.48 million02/15/2024$11.48$11.48$11.48$11.483 shs$76.33 million02/14/2024$11.48$11.48$11.48$11.489 shs$76.34 million02/09/2024$11.48$11.48$11.48$11.4811 shs$76.34 million02/08/2024$11.48$11.48$11.48$11.28485 shs$76.34 million02/07/2024$11.29$11.48+1.68%$11.48$11.28485 shs$76.34 million02/06/2024$11.29$11.29$11.29$11.292 shs$75.08 million02/05/2024$11.36$11.29-0.62%$11.38$11.23811 shs$75.07 million02/02/2024$11.35$11.36+0.09%$11.40$11.291,519 shs$75.54 million02/01/2024$11.26$11.35+0.80%$11.41$11.251,438 shs$75.48 million01/31/2024$11.37$11.26-0.97%$11.42$11.213,060 shs$74.88 million01/30/2024$11.37$11.37$11.37$11.37275 shs$75.61 million01/29/2024$11.36$11.37+0.09%$11.37$11.37275 shs$75.61 million01/26/2024$11.36$11.36$11.36$11.36176,312 shs$75.54 million01/25/2024$11.29$11.36+0.62%$11.36$11.36176,312 shs$75.54 million01/24/2024$11.36$11.29-0.62%$11.42$11.29418 shs$75.08 million01/23/2024$11.22$11.36+1.25%$11.36$11.201,906 shs$75.54 million Related Companies: Checkpoint Therapeutics Stock Price Chart HCW Biologics Stock Price Chart Eagle Pharmaceuticals Stock Price Chart Kezar Life Sciences Stock Price Chart Vaxxinity Stock Price Chart Lantern Pharma Stock Price Chart Reneo Pharmaceuticals Stock Price Chart Equillium Stock Price Chart Homology Medicines Stock Price Chart Kronos Bio Stock Price Chart Receive VHAQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viveon Health Acquisition and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:VHAQ) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveon Health Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
